Exhaled nitric oxide in pediatric asthma



Exhaled nitric oxide can now be measured in a clinical setting as a noninvasive, reproducible, facile, point-of-service test to measure airway inflammation, a central component of asthma that had not been assessed previously. An excellent surrogate marker of steroid-responsive eosinophilic airway inflammation, it serves to identify steroid-sensitive asthmatic patients and enables clinical monitoring of the response to steroid therapy and titration of the dose. Standardization of methodology and technological advances, such as the recent availability of handheld analyzers, individualized patient cards to store serial test measurements, and the assignment of coding procedural terminology, make this a necessary adjunct to clinical and functional assessment of airway obstruction and hyperresponsiveness in ambulatory pediatric and adult asthma practices.

References and Recommended Reading

  1. 1.
    Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007, 120(5 Suppl):S94–S138.Google Scholar
  2. 2.
    Dinakar C: Exhaled nitric oxide in the clinical management of asthma. Curr Allergy Asthma Rep 2004, 4:454–459.PubMedCrossRefGoogle Scholar
  3. 3.
    Alving K, Weitzberg E, Lundberg JM: Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993, 6:1368–1370.PubMedGoogle Scholar
  4. 4.
    Kharitonov SA, Yates D, Springall DR, et al.: Exhaled nitric oxide is increased in asthma. Chest 1995, 107(3 Suppl):156S–157S.PubMedCrossRefGoogle Scholar
  5. 5.
    Gao PS, Kawada H, Kasamatsu T, et al.: Variants of NOS1, NOS2, and NOS3 genes in asthmatics. Biochem Biophys Res Commun 2000, 267:761–763.PubMedCrossRefGoogle Scholar
  6. 6.
    Zitt M: Clinical applications of exhaled nitric oxide for the diagnosis and management of asthma: a consensus report. Clin Ther 2005, 27:1238–1250.PubMedCrossRefGoogle Scholar
  7. 7.
    ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005, 171:912–930.Google Scholar
  8. 8.
    Silkoff PE, Carlson M, Bourke T, et al.: The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. J Allergy Clin Immunol 2004, 114:1241–1256.PubMedCrossRefGoogle Scholar
  9. 9.
    Lim KG, Mottram C: The use of fraction of exhaled nitric oxide in pulmonary practice. Chest 2008, 133:1232–1242.PubMedCrossRefGoogle Scholar
  10. 10.
    NIOX MINO product features. Available at http://www.nioxmino.com/US/features.html Accessed August 1, 2008.
  11. 11.
    Menzies D, Nair A, Lipworth BJ: Portable exhaled nitric oxide measurement: comparison with the “gold standard” technique. Chest 2007, 131:410–414.PubMedCrossRefGoogle Scholar
  12. 12.
    Khalili B, Boggs PB, Bahna SL: Reliability of a new handheld device for the measurement of exhaled nitric oxide. Allergy 2007, 62:1171–1174.PubMedCrossRefGoogle Scholar
  13. 13.
    Kostikas K, Papaioannou AI, Tanou K, et al.: Portable exhaled nitric oxide as a screening tool for asthma in young adults during pollen season. Chest 2008, 133:906–913.PubMedCrossRefGoogle Scholar
  14. 14.
    Apieron. Available at http://www.apieron.com. Accessed August 1, 2008.
  15. 15.
    Moeller A, Diefenbacher C, Lehmann A, et al.: Exhaled nitric oxide distinguishes between subgroups of preschool children with respiratory symptoms. J Allergy Clin Immunol 2008, 121:705–709.PubMedCrossRefGoogle Scholar
  16. 16.
    Perzanowski MS, Rosa MJ, Divjan A, et al.: Modifications improve an offline exhaled nitric oxide collection device for use with young children. J Allergy Clin Immunol 2008, 122:213; author reply 214.PubMedCrossRefGoogle Scholar
  17. 17.
    Olivieri M, Talamini G, Corradi M, et al.: Reference values for exhaled nitric oxide (reveno) study. Respir Res 2006, 7:94.PubMedCrossRefGoogle Scholar
  18. 18.
    Travers J, Marsh S, Aldington S, et al.: Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med 2007, 176:238–242.PubMedCrossRefGoogle Scholar
  19. 19.
    Buchvald F, Baraldi E, Carraro S, et al.: Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J Allergy Clin Immunol 2005, 115:1130–1136.PubMedCrossRefGoogle Scholar
  20. 20.
    Malmberg LP, Petays T, Haahtela T, et al.: Exhaled nitric oxide in healthy nonatopic school-age children: determinants and height-adjusted reference values. Pediatr Pulmonol 2006, 41:635–642.PubMedCrossRefGoogle Scholar
  21. 21.
    Levesque MC, Hauswirth DW, Mervin-Blake S, et al.: Determinants of exhaled nitric oxide levels in healthy, nonsmoking African American adults. J Allergy Clin Immunol 2008, 121:396–402.PubMedCrossRefGoogle Scholar
  22. 22.
    De Winter-de Groot KM, Van der Ent CK, Prins I, et al.: Exhaled nitric oxide: the missing link between asthma and obesity? J Allergy Clin Immunol 2005, 115:419–420.PubMedCrossRefGoogle Scholar
  23. 23.
    Maniscalco M, de Laurentiis G, Zedda A, et al.: Exhaled nitric oxide in severe obesity: effect of weight loss. Respir Physiol Neurobiol 2007, 156:370–373.PubMedCrossRefGoogle Scholar
  24. 24.
    Santamaria F, Montella S, De Stefano S, et al.: Relationship between exhaled nitric oxide and body mass index in children and adolescents. J Allergy Clin Immunol 2005, 116:1163–1164; author reply 1164–1165.PubMedCrossRefGoogle Scholar
  25. 25.
    Stewart L, Katial R: Exhaled nitric oxide. Immunol Allergy Clin North Am 2007, 27:571–586.PubMedCrossRefGoogle Scholar
  26. 26.
    Dinakar C, Craff M, Laskowski D: Infants and toddlers without asthma with eczema have elevated exhaled nitric oxide levels. J Allergy Clin Immunol 2006, 117:212–213.PubMedCrossRefGoogle Scholar
  27. 27.
    Lund MB, Kongerud J, Nystad W, et al.: Genetic and environmental effects on exhaled nitric oxide and airway responsiveness in a population-based sample of twins. Eur Respir J 2007, 29:292–298.PubMedCrossRefGoogle Scholar
  28. 28.
    Dinakar C, Lapuente M, Barnes C, et al.: Real-life environmental tobacco exposure does not affect exhaled nitric oxide levels in asthmatic children. J Asthma 2005, 42:113–118.PubMedCrossRefGoogle Scholar
  29. 29.
    Silkoff PE, McClean P, Spino M, et al.: Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest 2001, 119:1322–1328.PubMedCrossRefGoogle Scholar
  30. 30.
    Kissoon N, Duckworth LJ, Blake KV, et al.: Effect of beta2-agonist treatment and spirometry on exhaled nitric oxide in healthy children and children with asthma. Pediatr Pulmonol 2002, 34:203–208.PubMedCrossRefGoogle Scholar
  31. 31.
    Silkoff PE, Romero FA, Gupta N, et al.: Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody. Pediatrics 2004, 113:e308–e312.PubMedCrossRefGoogle Scholar
  32. 32.
    Roberts G, Hurley C, Turcanu V, et al.: Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. J Allergy Clin Immunol 2006, 117:263–268.PubMedCrossRefGoogle Scholar
  33. 33.
    Dinakar C, Van Osdol TJ, Barnes CS, et al.: Changes in exhaled nitric oxide levels with immunotherapy. Allergy Asthma Proc 2006, 27:140–144.PubMedGoogle Scholar
  34. 34.
    Lex C, Ferreira F, Zacharasiewicz A, et al.: Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests. Am J Respir Crit Care Med 2006, 174:1286–1291.PubMedCrossRefGoogle Scholar
  35. 35.
    Erin EM, Zacharasiewicz AS, Nicholson GC, et al.: Rapid effect of inhaled ciclesonide in asthma: a randomized, placebo-controlled study. Chest 2008, 134:740–745.PubMedCrossRefGoogle Scholar
  36. 36.
    Smith AD, Cowan JO, Brassett KP, et al.: Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med 2005, 172:453–459.PubMedCrossRefGoogle Scholar
  37. 37.
    Silkoff PE, Lent AM, Busacker AA, et al.: Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. J Allergy Clin Immunol 2005, 116:1249–1255.PubMedCrossRefGoogle Scholar
  38. 38.
    Fitzpatrick AM, Gaston BM, Erzurum SC, et al.: Features of severe asthma in school-age children: atopy and increased exhaled nitric oxide. J Allergy Clin Immunol 2006, 118:1218–1222.PubMedCrossRefGoogle Scholar
  39. 39.
    Grob NM, Dweik RA: Exhaled nitric oxide in asthma. From diagnosis, to monitoring, to screening: are we there yet? Chest 2008, 133:837–839.PubMedCrossRefGoogle Scholar
  40. 40.
    Smith AD, Cowan JO, Filsell S, et al.: Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med 2004, 169:473–478.PubMedCrossRefGoogle Scholar
  41. 41.
    Taylor DR: Nitric oxide as a clinical guide for asthma management. J Allergy Clin Immunol 2006, 117:259–262.PubMedCrossRefGoogle Scholar
  42. 42.
    Szefler SJ, Phillips BR, Martinez FD, et al.: Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005, 115:233–242.PubMedCrossRefGoogle Scholar
  43. 43.
    Zeiger RS, Szefler SJ, Phillips BR, et al.: Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol 2006, 117:45–52.PubMedCrossRefGoogle Scholar
  44. 44.
    Hahn PY, Morgenthaler TY, Lim KG: Use of exhaled nitric oxide in predicting response to inhaled corticosteroids for chronic cough. Mayo Clin Proc 2007, 82:1350–1355.PubMedCrossRefGoogle Scholar
  45. 45.
    Smith AD, Cowan JO, Brassett KP, et al.: Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005, 352:2163–2173.PubMedCrossRefGoogle Scholar
  46. 46.
    Jones SL, Kittelson J, Cowan JO, et al.: The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001, 164:738–743.PubMedGoogle Scholar
  47. 47.
    Pijnenburg MW, Hofhuis W, Hop WC, et al.: Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax 2005, 60:215–218.PubMedCrossRefGoogle Scholar
  48. 48.
    Zacharasiewicz A, Wilson N, Lex C, et al.: Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005, 171:1077–1082.PubMedCrossRefGoogle Scholar
  49. 49.
    Delgado-Corcoran C, Kissoon N, Murphy SP, et al.: Exhaled nitric oxide reflects asthma severity and asthma control. Pediatr Crit Care Med 2004, 5:48–52.PubMedCrossRefGoogle Scholar
  50. 50.
    Green RH, Brightling CE, McKenna S, et al.: Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002, 360:1715–1721.PubMedCrossRefGoogle Scholar
  51. 51.
    Shaw DE, Berry MA, Thomas M, et al.: The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med 2007, 176:231–237.PubMedCrossRefGoogle Scholar
  52. 52.
    Pijnenburg MW, Bakker EM, Hop WC, et al.: Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 2005, 172:831–836.PubMedCrossRefGoogle Scholar
  53. 53.
    Petsky HL, Cates CJ, Li AM, et al.: Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev 2008, 2:CD006340.PubMedGoogle Scholar
  54. 54.
    Taylor DR: Exhaled NO: forward, backward, or sideways? Am J Respir Crit Care Med 2007, 176:221–222.PubMedCrossRefGoogle Scholar
  55. 55.
    Malmberg LP, Pelkonen AS, Haahtela T, Turpeinen M: Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma. Thorax 2003, 58:494–499.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Section of Allergy, Asthma, and ImmunologyChildren’s Mercy Hospital and ClinicsKansas CityUSA

Personalised recommendations